Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Engineered Functional Redundancy Relaxes Selective Constraints upon Endogenous Genes in Viral RNA Genomes.

Ambrós S, de la Iglesia F, Rosario SM, Butkovic A, Elena SF.

Genome Biol Evol. 2018 Jul 1;10(7):1823-1836. doi: 10.1093/gbe/evy141.

2.

Stability of the anterior arm of three different Hyrax hybrid expanders: an in vitro study.

de la Iglesia G, Walter A, de la Iglesia F, Winsauer H, Puigdollers A.

Dental Press J Orthod. 2018 Jan;23(1):37-45. doi: 10.1590/2177-6709.23.1.037-045.oar.

3.

Closing extraction spaces with lingual orthodontics.

Ishida A, de la Iglesia F, Molina A, Hiro T, Puigdollers A.

Int J Orthod Milwaukee. 2012 Winter;23(4):15-20.

PMID:
23413637
4.

Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain.

de la Iglesia FA, Pace GW, Robinson GL, Huang NY, Stern W, Richards P.

J Opioid Manag. 2012 Mar-Apr;8(2):89-98.

PMID:
22616314
5.

Luria-delbruck estimation of turnip mosaic virus mutation rate in vivo.

de la Iglesia F, Martínez F, Hillung J, Cuevas JM, Gerrish PJ, Daròs JA, Elena SF.

J Virol. 2012 Mar;86(6):3386-8. doi: 10.1128/JVI.06909-11. Epub 2012 Jan 11.

6.

Tempo and mode of plant RNA virus escape from RNA interference-mediated resistance.

Lafforgue G, Martínez F, Sardanyés J, de la Iglesia F, Niu QW, Lin SS, Solé RV, Chua NH, Daròs JA, Elena SF.

J Virol. 2011 Oct;85(19):9686-95. doi: 10.1128/JVI.05326-11. Epub 2011 Jul 20.

7.

The evolutionary genetics of emerging plant RNA viruses.

Elena SF, Bedhomme S, Carrasco P, Cuevas JM, de la Iglesia F, Lafforgue G, Lalić J, Pròsper A, Tromas N, Zwart MP.

Mol Plant Microbe Interact. 2011 Mar;24(3):287-93. doi: 10.1094/MPMI-09-10-0214. Review.

8.

Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Roca B, Almagro P, López F, Cabrera FJ, Montero L, Morchón D, Díez J, de la Iglesia F, Fernández M, Castiella J, Zubillaga E, Recio J, Soriano JB; ECCO Working Group on COPD; Spanish Society of Internal Medicine.

Intern Emerg Med. 2011 Feb;6(1):47-54. doi: 10.1007/s11739-010-0465-7. Epub 2010 Oct 1.

PMID:
20886377
9.

[Study of the comorbidities in hospitalized patients due to decompensated chronic obstructive pulmonary disease attended in the Internal Medicine Services. ECCO Study].

Almagro P, López García F, Cabrera FJ, Montero L, Morchón D, Díez J, de la Iglesia F, Roca FB, Fernández-Ruiz M, Castiella J, Zubillaga E, Recio J, Soriano JB; Grupo EPOC de la Sociedad Española de Medicina Interna.

Rev Clin Esp. 2010 Mar;210(3):101-8. doi: 10.1016/j.rce.2009.12.002. Spanish.

PMID:
20226938
10.

[Factor analysis of health related quality of life in patients admitted to a short stay medical unit].

Seoane B, de la Iglesia F, Nicolás R, Ramos V, Pellicer C, Diz-Lois F.

Rev Med Chil. 2009 Sep;137(9):1163-72. doi: /S0034-98872009000900004. Spanish.

11.

Hemostatic properties of a venomic protein in rat organ trauma.

Warner RL, McClintock SD, Barron AG, de la Iglesia FA.

Exp Mol Pathol. 2009 Dec;87(3):204-11. doi: 10.1016/j.yexmp.2009.09.004. Epub 2009 Sep 10.

12.

The pleiotropic cost of host-specialization in Tobacco etch potyvirus.

Agudelo-Romero P, de la Iglesia F, Elena SF.

Infect Genet Evol. 2008 Dec;8(6):806-14. doi: 10.1016/j.meegid.2008.07.010. Epub 2008 Aug 14.

PMID:
18765302
13.

Changes in the gene expression profile of Arabidopsis thaliana after infection with Tobacco etch virus.

Agudelo-Romero P, Carbonell P, de la Iglesia F, Carrera J, Rodrigo G, Jaramillo A, Pérez-Amador MA, Elena SF.

Virol J. 2008 Aug 7;5:92. doi: 10.1186/1743-422X-5-92.

14.

Distribution of fitness and virulence effects caused by single-nucleotide substitutions in Tobacco Etch virus.

Carrasco P, de la Iglesia F, Elena SF.

J Virol. 2007 Dec;81(23):12979-84. Epub 2007 Sep 26.

15.

Hemostatic properties of a venomic protein in rodent dermal injuries.

Warner RL, McClintock SD, Barron AG, de la Iglesia F.

Exp Mol Pathol. 2007 Oct;83(2):241-8. Epub 2007 May 18.

PMID:
17574547
16.

Fitness declines in Tobacco etch virus upon serial bottleneck transfers.

de la Iglesia F, Elena SF.

J Virol. 2007 May;81(10):4941-7. Epub 2007 Mar 7.

17.

Intestinal mucosa remodeling by recombinant human epidermal growth factor(1-48) in neonates with severe necrotizing enterocolitis.

Sullivan PB, Lewindon PJ, Cheng C, Lenehan PF, Kuo BS, Haskins JR, Goodlad RA, Wright NA, de la Iglesia FA.

J Pediatr Surg. 2007 Mar;42(3):462-9. Erratum in: J Pediatr Surg. 2007 Aug;42(8):1470. dela Iglesia, Felix A [corrected to de la Iglesia, Felix A].

PMID:
17336181
18.

Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease.

de la Iglesia F, Díaz JL, Pita S, Nicolás R, Ramos V, Pellicer C, Diz-Lois F.

South Med J. 2005 Mar;98(3):266-72.

PMID:
15813152
19.

Co-administration of oxycodone and morphine and analgesic synergy re-examined.

Smith MT, de la Iglesia FA.

Br J Clin Pharmacol. 2005 Apr;59(4):486-7; author reply 487-8. No abstract available.

20.

Genetic and pathologic significance of 1p, 17p, and 18q aneusomy and the ERBB2 gene in colorectal cancer and related normal colonic mucosa.

Cianciulli A, Cosimelli M, Marzano R, Merola R, Piperno G, Sperduti I, de la Iglesia F, Leonardo G, Graziano F, Mancini R, Guadagni F.

Cancer Genet Cytogenet. 2004 May;151(1):52-9.

PMID:
15120910
21.

Acute renal infarction as a cause of low-back pain.

de la Iglesia F, Asensio P, Díaz A, Darriba M, Nicolás R, Diz-Lois F.

South Med J. 2003 May;96(5):497-9.

PMID:
12911191
22.

Rodent carcinogenicity with the thiazolidinedione antidiabetic agent troglitazone.

Herman JR, Dethloff LA, McGuire EJ, Parker RF, Walsh KM, Gough AW, Masuda H, de la Iglesia FA.

Toxicol Sci. 2002 Jul;68(1):226-36.

PMID:
12075125
23.

Factors predicting a hospital stay of over 3 days in patients with acute exacerbation of chronic obstructive pulmonary disease.

de la Iglesia F, Valiño P, Pita S, Ramos V, Pellicer C, Nicolás R, Diz-Lois F.

J Intern Med. 2002 Jun;251(6):500-7.

24.

Chronic toxicity in monkeys with the thiazolidinedione antidiabetic agent troglitazone.

Rothwell C, McGuire EJ, Altrogge DM, Masuda H, de la Iglesia FA.

J Toxicol Sci. 2002 Feb;27(1):35-47.

26.

Systemic proliferative changes and clinical signs in cynomolgus monkeys administered a recombinant derivative of human epidermal growth factor.

Reindel JF, Gough AW, Pilcher GD, Bobrowski WF, Sobocinski GP, de la Iglesia FA.

Toxicol Pathol. 2001 Mar-Apr;29(2):159-73.

PMID:
11421483
27.

RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays.

Bulera SJ, Eddy SM, Ferguson E, Jatkoe TA, Reindel JF, Bleavins MR, De La Iglesia FA.

Hepatology. 2001 May;33(5):1239-58.

PMID:
11343254
28.

Pharmacogenetic application in drug development and clinical trials.

Shi MM, Bleavins MR, de la Iglesia FA.

Drug Metab Dispos. 2001 Apr;29(4 Pt 2):591-5.

PMID:
11259358
29.

Genotyping for Functionally Important Human CYP2D6*4 (B) Mutation Using TaqMan Probes.

Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA.

Methods Mol Med. 2001;49:459-72. doi: 10.1385/1-59259-081-0:459.

PMID:
21370161
30.

Gabapentin-induced mitogenic activity in rat pancreatic acinar cells.

Dethloff L, Barr B, Bestervelt L, Bulera S, Sigler R, LaGattuta M, de La Iglesia F.

Toxicol Sci. 2000 May;55(1):52-9.

PMID:
10788559
32.

Technologies for detecting genetic polymorphisms in pharmacogenomics.

Shi MM, Bleavins MR, de la iglesia FA.

Mol Diagn. 1999 Dec;4(4):343-51. Review.

PMID:
10671645
33.

Troglitazone-induced heart and adipose tissue cell proliferation in mice.

Breider MA, Gough AW, Haskins JR, Sobocinski G, de la Iglesia FA.

Toxicol Pathol. 1999 Sep-Oct;27(5):545-52.

PMID:
10528634
34.

Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.

Duddy SK, Gorospe SM, Bleavins MR, de la Iglesia FA.

Toxicol Appl Pharmacol. 1999 Oct 15;160(2):133-40.

PMID:
10527912
35.

High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes.

Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA.

Res Commun Mol Pathol Pharmacol. 1999 Jan;103(1):3-15.

PMID:
10440566
36.

In vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity.

Bulera SJ, Theiss JC, Festerling TA, de la Iglesia FA.

Toxicol Appl Pharmacol. 1999 May 1;156(3):222-30.

PMID:
10222314
37.

p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.

Duddy SK, Parker RF, Bleavins MR, Gough AW, Rowse PE, Gorospe S, Dethloff LA, de la Iglesia FA.

Toxicol Appl Pharmacol. 1999 Apr 15;156(2):106-12.

PMID:
10198275
38.

[Cellulitis from Acinetobacter].

Merayo E, Míguez E, de la Iglesia F, Llinares P, Echániz A.

Enferm Infecc Microbiol Clin. 1999 Feb;17(2):101-2. Spanish. No abstract available.

PMID:
10193076
39.

Monitoring simultaneous subcellular events in vitro by means of coherent multiprobe fluorescence.

Plymale DR, Haskins JR, de la Iglesia FA.

Nat Med. 1999 Mar;5(3):351-5. No abstract available.

PMID:
10086396
40.

Acridine-induced subcellular and functional changes in isolated human hepatocytes in vitro.

Plymale DR, de la Iglesia FA.

J Appl Toxicol. 1999 Jan-Feb;19(1):31-8.

PMID:
9989475
41.

Elucidation of mitochondrial effects by tetrahydroaminoacridine (tacrine) in rat, dog, monkey and human hepatic parenchymal cells.

Robertson DG, Braden TK, Urda ER, Lalwani ND, de la Iglesia FA.

Arch Toxicol. 1998 May;72(6):362-71.

PMID:
9657284
42.

Chemical-induced hepatocyte ploidy.

Dethloff LA, de la Iglesia FA.

Toxicol Appl Pharmacol. 1998 Jun;150(2):443. No abstract available.

PMID:
9653075
43.

Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine.

Monteith DK, Theiss JC, Haskins JR, de la Iglesia FA.

Arch Toxicol. 1998 Feb;72(3):147-56.

PMID:
9520138
44.

alpha2u-Globulin nephropathy and ravens: do ravens of a different feather flock together?

de la Iglesia FA, Gough AW, Sigler RE.

Environ Health Perspect. 1997 Sep;105(9):903-4. No abstract available.

45.

Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.

Lalwani ND, Dethloff LA, Haskins JR, Robertson DG, de la Iglesia FA.

Toxicol Pathol. 1997 Mar-Apr;25(2):165-76.

PMID:
9125775
46.

Structural diversity of peroxisome proliferators and their effects on mammalian liver cells in vivo.

de la Iglesia F, McGuire EJ, Haskins JR, Lalwani ND.

Ann N Y Acad Sci. 1996 Dec 27;804:310-27. No abstract available.

PMID:
8993553
47.

Recombinant human epidermal growth factor1-48-induced structural changes in the digestive tract of cynomolgus monkeys (Macaca fascicularis).

Reindel JF, Pilcher GD, Gough AW, Haskins JR, de la Iglesia FA.

Toxicol Pathol. 1996 Nov-Dec;24(6):669-80.

PMID:
9082544
48.

Preclinical toxicology studies with the angiotensin-converting enzyme inhibitor quinapril hydrochloride (Accupril).

McGuire EJ, Anderson JA, Gough AW, Herman JR, Pegg DG, Theiss JC, de la Iglesia FA.

J Toxicol Sci. 1996 Nov;21(4):207-14. Review.

PMID:
8959644
49.

Perspective on the carcinogenic potential of phenytoin based on rodent tumor bioassays and human epidemiological data.

Dethloff LA, Graziano MJ, Goldenthal E, Gough A, de la Iglesia FA.

Hum Exp Toxicol. 1996 Apr;15(4):335-48.

PMID:
8845224
50.

Cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor.

Breider MA, Bleavins MR, Reindel JF, Gough AW, de la Iglesia FA.

Vet Pathol. 1996 Mar;33(2):184-94.

PMID:
8801712

Supplemental Content

Loading ...
Support Center